386 related articles for article (PubMed ID: 29347917)
21. Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity.
Colagiuri B
Clin Trials; 2010 Jun; 7(3):246-55. PubMed ID: 20421243
[TBL] [Abstract][Full Text] [Related]
22. Selecting a control for in vitro fertilization and acupuncture randomized controlled trials (RCTs): how sham controls may unnecessarily complicate the RCT evidence base.
Manheimer E
Fertil Steril; 2011 Jun; 95(8):2456-61. PubMed ID: 21570069
[TBL] [Abstract][Full Text] [Related]
23. Informing Adults With Back Pain About Placebo Effects: Randomized Controlled Evaluation of a New Website With Potential to Improve Informed Consent in Clinical Research.
Bishop FL; Greville-Harris M; Bostock J; Din A; Graham CA; Lewith G; Liossi C; O'Riordan T; White P; Yardley L
J Med Internet Res; 2019 Jan; 21(1):e9955. PubMed ID: 30664462
[TBL] [Abstract][Full Text] [Related]
24. Tapping-in method (skin penetration technique) with a placebo needle for double-blind acupuncture trials.
Takakura N; Takayama M; Kawase A; Yajima H
J Altern Complement Med; 2013 Apr; 19(4):308-12. PubMed ID: 23098695
[TBL] [Abstract][Full Text] [Related]
25. A survey of study participants' understanding of informed consent to participate in a randomised controlled trial of acupuncture.
Smith CA; Fogarty S
BMC Complement Altern Med; 2016 Jan; 16():10. PubMed ID: 26753767
[TBL] [Abstract][Full Text] [Related]
26. Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when.
Bjorklund M; Shiely F; Gillies K
PLoS One; 2022; 17(5):e0268898. PubMed ID: 35609047
[TBL] [Abstract][Full Text] [Related]
27. Acupuncture for insomnia.
Cheuk DK; Yeung WF; Chung KF; Wong V
Cochrane Database Syst Rev; 2007 Jul; (3):CD005472. PubMed ID: 17636800
[TBL] [Abstract][Full Text] [Related]
28. [Thinking about the conclusion of no difference between the acupuncture and sham-acupuncture in the clinically therapeutic effects on migraine abroad].
Wang JJ; Wu ZC
Zhongguo Zhen Jiu; 2009 Apr; 29(4):315-9. PubMed ID: 19565742
[TBL] [Abstract][Full Text] [Related]
29. Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer.
Partridge AH; Sepucha K; O'Neill A; Miller KD; Motley C; Swaby RF; Schneider BP; Dang CT; Northfelt DW; Sledge GW
JAMA Oncol; 2015 Jun; 1(3):369-74. PubMed ID: 26114161
[TBL] [Abstract][Full Text] [Related]
30. Double-blinding of an acupuncture randomized controlled trial optimized with clinical translational science award resources.
Steffen AD; Burke LA; Pauls HA; Suarez ML; Yao Y; Kobak WH; Takayama M; Yajima H; Kaptchuk TJ; Takakura N; Wilkie DJ; Schlaeger JM
Clin Trials; 2020 Oct; 17(5):545-551. PubMed ID: 32650673
[TBL] [Abstract][Full Text] [Related]
31. Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010.
Baethge C; Assall OP; Baldessarini RJ
Psychother Psychosom; 2013; 82(3):152-60. PubMed ID: 23548796
[TBL] [Abstract][Full Text] [Related]
32. The Effect of Positively Framing Side-Effect Risk in Two Different Formats on Side-Effect Expectations, Informed Consent and Credibility: A Randomised Trial of 16- to 75-Year-Olds in England.
Webster RK; Rubin GJ
Drug Saf; 2020 Oct; 43(10):1011-1022. PubMed ID: 32557180
[TBL] [Abstract][Full Text] [Related]
33. Influence of blinding on treatment effect size estimate in randomized controlled trials of oral health interventions.
Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
BMC Med Res Methodol; 2018 May; 18(1):42. PubMed ID: 29776394
[TBL] [Abstract][Full Text] [Related]
34. A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain.
Bergmann JF; Chassany O; Gandiol J; Deblois P; Kanis JA; Segrestaa JM; Caulin C; Dahan R
Clin Trials Metaanal; 1994 Apr; 29(1):41-7. PubMed ID: 10150184
[TBL] [Abstract][Full Text] [Related]
35. Blinding strategies in the conduct and reporting of a randomized placebo-controlled device trial.
Houweling AH; Shapiro S; Cohen JM; Kahn SR
Clin Trials; 2014 Oct; 11(5):547-52. PubMed ID: 24902921
[TBL] [Abstract][Full Text] [Related]
36. The quality of placebos used in randomized, controlled trials of lumbar and pelvic joint thrust manipulation-a systematic review.
Puhl AA; Reinhart CJ; Doan JB; Vernon H
Spine J; 2017 Mar; 17(3):445-456. PubMed ID: 27888138
[TBL] [Abstract][Full Text] [Related]
37. Positively Framed Risk Information in Patient Information Leaflets Reduces Side Effect Reporting: A Double-Blind Randomized Controlled Trial.
Webster RK; Weinman J; Rubin GJ
Ann Behav Med; 2018 Oct; 52(11):920-929. PubMed ID: 30346496
[TBL] [Abstract][Full Text] [Related]
38. Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups? A protocol for a meta-epidemiological study of PDE-5 inhibitors.
Feys F; Bekkering GE; Singh K; Devroey D
Syst Rev; 2012 Nov; 1():54. PubMed ID: 23151403
[TBL] [Abstract][Full Text] [Related]
39. Nocebo vs. placebo: the challenges of trial design in analgesia research.
Vase L; Amanzio M; Price DD
Clin Pharmacol Ther; 2015 Feb; 97(2):143-50. PubMed ID: 25670519
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
